2017 QCDR Measures

PQRS Measures

2016 PQRS Measures List

There are four process measures relative to oncology in the 2016 PQRS measure set:

#071:  Breast Cancer: Hormonal Therapy for Stage IC -IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast Cancer

Measure description:  Percentage of female patients aged 18 years and older with Stage IC through IIIC, ER or PR positive breast cancer who were prescribed tamoxifen or aromatase inhibitor (AI) during the 12-month reporting period

#072: Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients

Measure Description: Percentage of patients aged 18 through 80 years with AJCC Stage III colon cancer who are referred for adjuvant chemotherapy, prescribed adjuvant chemotherapy, or have previously received adjuvant chemotherapy within the 12-month reporting period.

#143: Oncology: Medical and Radiation – Pain Intensity Quantified

Measure Description:  Percentage of patients, regardless of patient age with a diagnosis of cancer currently receiving chemotherapy or radiation therapy in which pain intensity is quantified.

#144: Oncology: Medical and Radiation – Plan of Care for Pain

Percentage of visits for patients, regardless of age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy who report having pain with a documented plan of care to address pain

Oncology Medical Group Measures
#       Measure Title          NQS Domain     
71 (NQF 0387) Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast Cancer Effective Clinical Care (Process) 
72 (NQF 0385) Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients

Effective Clinical Care (Process) 

110 (NQF 0041)  Preventive Care and Screening: Influenza Immunization Community/Population Health (Process)
130 (NQF 0419) Documentation of Current Medications in the Medical Record Patient Safety (Process) 
143 (NQF 0384) Oncology: Medical and radiation - Pain Intensified Quantified Person and Caregiver-Centered Experience and Outcomes (Process) 
144 (NQF 0383) Oncology: Medical and Radiation - Plan of care for Pain Person and Caregiver-Centered Experience and Outcomes (Process) 
226 (NQF 0028)  Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention Community/Population Health (Process) 

 

QCDR Measures

 

# Measure Title NQS Domain
Core 2 (NQF 386) Staging documented within one month of first office visit Effective Clinical Care (Process)
Core 4a (NQF 384) Pain intensity quantified by second office visit Person and Caregiver-Centered Experience and Outcomes (Process)
Core 10 Chemotherapy intent documented before or within two weeks after administration Person and Caregiver-Centered Experience and Outcomes (Process)
Core 13aa Performance status documented prior to initiating chemotherapy regimen Efficiency and Cost Reduction (Process)
Core 13a1 Chemotherapy administered to patients with metastatic solid tumors and performance status of 3, 4, or undocumented (lower score – better)  Efficiency and Cost Reduction (Process)
Core 21a (NQF 28)  Smoking status/tobacco use documented in past year Community/Population Health (Process) 
Core 25a (NQF 326) Documentation of patient's advance directives by the third office visit Person and Caregiver-Centered Experience and Outcomes (Process)
Core 25e GCSF administered to patients who received chemotherapy for metastatic cancer (Lower score-better)  Efficiency and Cost Reduction (Process)
Symptom 29a  Antiemetic therapy prescribed for highly emetogenic chemotherapy  Effective Clinical Care (Process)
Symptom 29c: Antiemetic therapy prescribed for moderately emetogenic chemotherapy Effective Clinical Care (Process)
EOL 36a (NQF 384)  Pain intensity quantified on either of the last two visits before death Person and Caregiver-Centered Experience and Outcomes (Process)
EOL 44a (NQF 216)   Hospice enrollment and enrolled more than 3 days before death Person and Caregiver-Centered Experience and Outcomes (Outcome) 
EOL 47f Location of death documented (*paired measure)  Effective Clinical Care (Process) 
EOL 47c2  Death from cancer in intensive care unit (*paired measure) Person and Caregiver-Centered Experience and Outcomes (Outcome)
EOL 48 (NQF 210)  Chemotherapy administered within last 2 weeks of life (Lower score – better)  Person and Caregiver-Centered Experience and Outcomes (Process) 
Breast 53 (NQF 559)  Combination chemotherapy received within 4 months of diagnosis by women under 70 with AJCC stage IA (T1c) and IB- III ER/PR negative breast cancer  Effective Clinical Care (Process) 
Breast 54 (NQF 1878) Test for Her2/neu overexpression or gene amplification  Effective Clinical Care (Process)
Breast 57 (NQF 1858) Trastuzumab received by patients with AJCC stage I (T1c) to III Her2/neu positive breast cancer Effective Clinical Care (Process) 
Breast 59 (NQF 387) Tamoxifen or AI received within 1 year of diagnosis by patients with AJCC stage IA (T1c) and IB - III ER or PR positive breast cancer Effective Clinical Care (Process) 
Colorectal 68 (NQF 385) Adjuvant chemotherapy received within 4 months of diagnosis by patients with AJCC stage III colon cancer Effective Clinical Care (Process) 

Access the Full QOPI 2016 QCDR Measures –Narrative PDF